Clinical trial
A Prospective, Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the ReVision Optics, Inc., RAINDROP® NEAR VISION INLAY for the Improvement of Near and Intermediate Vision in Pseudophakic Subjects
NCT02668523 is registered in ClinicalTrials.gov with ReVision Optics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter Clinical Trial to Evaluate the Safety and Effectiveness of the ReVision Optics, Inc., RAINDROP® NEAR VISION INLAY for the Improvement of Near and Intermediate Vision in Pseudophakic Subjects
- Lead sponsor
- ReVision Optics, Inc.
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- December 31, 2015
- Completion date
- July 31, 2018
- Enrollment
- 400 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.